THIOLA EC Delayed-release tablet Ref.[50386] Active ingredients: Tiopronin

Source: FDA, National Drug Code (US)  Revision Year: 2021 

Product description

THIOLA EC (tiopronin) delayed-release tablets are a reducing and cystine-binding thiol drug (CBTD) for oral use. Tiopronin is Nโ€‘(2โ€‘Mercaptopropionyl) glycine and has the following structure:

Tiopronin has the empirical formula C5H9NO3S and a molecular weight of 163.20. In this drug product tiopronin exists as a dl racemic mixture.

Tiopronin is a white crystalline powder, which is freely soluble in water.

Each THIOLA EC tablet contains 100 or 300 mg of tiopronin. The inactive ingredients in THIOLA EC tablets include lactose monohydrate, hydroxypropyl cellulose, hydroxypropyl cellulose (low substitute), magnesium stearate, hydroxypropyl methylcellulose E5, methacrylic acid: ethyl acrylate copolymer (Eudragit L 100-55), talc, triethyl citrate.

Dosage Forms and Strengths

Tablets for oral use:

100 mg tablets: round, white to off-white and imprinted in red with “T1” on one side.

300 mg tablets: round, white to off-white and imprinted in red with “T3” on one side.

How Supplied

100 mg delayed-release, round, white to off-white tablet imprinted with “T1” on one side with red ink and blank on the other side: Bottles of 300 NDC 0178-0902-01.

300 mg delayed-release, round, white to off-white tablet imprinted with “T3” on one side with red ink and blank on the other side: Bottles of 90 NDC 0178-0901-90.

Manufactured and packaged by Mission Pharmacal Company, San Antonio, TX 78230 1355

Distributed by Travere Therapeutics, Inc., San Diego, CA 92130

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.